The pandemic and Brexit deadline have caused a slump in the number of foreign firms planning to invest in the UK’s financial services industry. 

Only 10 per cent of global financial services companies plan to establish or expand operations in Britain in the next year, down from 45 per cent in April, according to accountancy firm EY. 

Overseas investors are increasingly focusing on the digital sector, real estate and construction and healthcare. 

Slump: Only 10 per cent of global financial services companies plan to establish or expand operations in Britain in the next year

Slump: Only 10 per cent of global financial services companies plan to establish or expand operations in Britain in the next year

Slump: Only 10 per cent of global financial services companies plan to establish or expand operations in Britain in the next year

Despite the downturn in short-term sentiment, 53 per cent of firms surveyed now expect the UK to be more attractive for foreign investment in three years’ time, up from 40 per cent earlier in the year. 

Douglas McWilliams, of the Centre for Economics and Business Research, suggested that pessimism surrounding the UK’s post-Brexit prospects may be being overdone.

#fiveDealsWidget .dealItemTitle#mobile {display:none} #fiveDealsWidget {display:block; float:left; clear:both; max-width:636px; margin:0; padding:0; line-height:120%; font-size:12px} #fiveDealsWidget div, #fiveDealsWidget a {margin:0; padding:0; line-height:120%; text-decoration: none; font-family:Arial, Helvetica ,sans-serif} #fiveDealsWidget .widgetTitleBox {display:block; float:left; width:100%; background-color:#af1e1e; } #fiveDealsWidget .widgetTitle {color:#fff; text-transform: uppercase; font-size:18px; font-weight:bold; margin:6px 10px 4px 10px; } #fiveDealsWidget a.dealItem {float:left; display:block; width:124px; margin-right:4px; margin-top:5px; background-color: #e3e3e3; min-height:200px;} #fiveDealsWidget a.dealItem#last {margin-right:0} #fiveDealsWidget .dealItemTitle {display:block; margin:10px 5px; color:#000; font-weight:bold} #fiveDealsWidget .dealItemImage, #fiveDealsWidget .dealItemImage img {float:left; display:block; margin:0; padding:0} #fiveDealsWidget .dealItemImage {border:1px solid #ccc} #fiveDealsWidget .dealItemImage img {width:100%; height:auto} #fiveDealsWidget .dealItemdesc {float:left; display:block; color:#004db3; font-weight:bold; margin:5px;} #fiveDealsWidget .dealItemRate {float:left; display:block; color:#000; margin:5px} #fiveDealsWidget .footerText a:hover{text-decoration: underline;} #fiveDealsWidget .footerSmall{font-size:10px; padding-top:10px;} @media (max-width: 635px) { #fiveDealsWidget a.dealItem {width:19%; margin-right:1%} #fiveDealsWidget a.dealItem#last {width:20%} } @media (max-width: 560px) { #fiveDealsWidget #desktop {display:none;} #fiveDealsWidget #mobile {display:block!important} #fiveDealsWidget a.dealItem {background-color: #fff; height:auto; min-height:auto} #fiveDealsWidget a.dealItem {border-bottom:1px solid #ececec; margin-bottom:5px; padding-bottom:10px} #fiveDealsWidget a.dealItem#last {border-bottom:0px solid #ececec; margin-bottom:5px; padding-bottom:0px} #fiveDealsWidget a.dealItem, #fiveDealsWidget a.dealItem#last {width:100%} #fiveDealsWidget .dealItemContent, #fiveDealsWidget .dealItemImage {float:left; display:inline-block} #fiveDealsWidget .dealItemImage {width:35%; margin-right:1%} #fiveDealsWidget .dealItemContent {width:63%} #fiveDealsWidget .dealItemTitle {margin: 0px 5px 5px; font-size:16px} #fiveDealsWidget .dealItemContent .dealItemdesc, #fiveDealsWidget .dealItemContent .dealItemRate {clear:both} }

This post first appeared on Dailymail.co.uk

You May Also Like

Atrato Onsite Energy investment trust to raise £150m with London IPO

Atrato Onsite Energy is set to become the first UK-listed investment trust…

What are fin-fluencers? Investing Explained

In this series, we bust the jargon and explain a popular investing…

Hot tub insurance claims tripled in 2020 after Britons rushed to buy them

Home insurance claims involving hot tubs almost tripled during 2020, new research…

AstraZeneca breast cancer drug Lynparza is approved by EU regulators

AstraZeneca’s drug pipeline was boosted after European regulators cleared one of its…